In many places, the emergence of this sector of the economy happened spontaneously. Take, for example, Silicon Valley. Or the growth of biotechnology businesses in the greater Boston area. Our state’s leaders understood that this sector was too important to Oklahoma’s long-term economic health (and the health of our population) to ignore. So they took some farsighted steps to try to catalyze the development of science and technology in Oklahoma.
News
An Emerging Tech Center: Oklahoma City notable home-grown startups in Innovation Magazine Copyright © 2016 | Innovation America Accele BioPharma (founded in 2011) — Biotechnology business accelerator located in the University Research Park, formed to create a capital-efficient mechanism to identify, finance and manage groundbreaking early stage life science technologies. http://accelebio.com Analytical Research Laboratories/DNA Solutions/The KupiecRead more
Dr. Elaine Hamm, vice president, Accele Biopharma Inc., will lead the students in the Who Wants to Be workshop where they will learn the basics of writing and presenting a business plan, including what investors are looking for in an entrepreneur.
From Staff Reports Copyright © 2015 The Oklahoma Publishing Co. i2E Inc. and Accele Venture Partners recently closed a $600,000 follow-on investment in Synereca Pharmaceuticals, a portfolio company of Accele Biopharma, an Oklahoma City-based biotechnology accelerator. With the most recent investment, Synereca has now received $2.5 million in funding to support its development of compoundsRead more
i2E and Accele Venture capital recently lead a $2.2 million investment in Pamilco Biopharma. i2E invested t through its Oklahoma Seed Capital Fund.
i2E, Inc., and Accele Venture Partners recently closed a $2.2 million investment in Pamlico Biopharma, Inc., a portfolio company of Accele Biopharma, an Oklahoma City-based biotechnology accelerator.
North Carolina native Clayton Duncan made a presentation to the Oklahoma Bioscience Roundtable, explaining why he chose Oklahoma to establish a biotech business accelerator rather than the Research Triangle Park.
Funded by the Accele Biopharma Business Accelerator, a startup company is learning to use vaccines to strip DNA from antibodies to feed it into specific germs.
